Christopher R. Polage, MD, MAS

Medical Director; Clinical Microbiology Laboratory
Duke University
Durham, NC

Disclosure: Alere: Other Financial or Material Support, Diagnostic Test Kits
BioFire Diagnostics: Consultant, Scientific Research Study Investigator, Advisor or Review Panel member
Cepheid: Other Financial or Material Support, Diagnostic Test Kits
Singulex: Consultant, Advisor or Review Panel member
TechLab: Other Financial or Material Support, Diagnostic Test Kits
Vedanta: Consultant, Advisor or Review Panel member

Presentation(s):

• 84 - Evaluation of the NHSN Standardized Infection Ratio (SIR) Risk Adjustment for HO-CDI in Oncology and ICU Patients in General Acute Care Hospitals

  Thursday, October 3
  11:00 AM – 11:15 AM

• 839 - Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals

  Thursday, October 3
  2:15 PM – 2:30 PM